1 / 14

GMP Compliance: Better to Start Now

GMP Compliance: Better to Start Now. Presented by: Matthew R. Weinberg, CEO. CURRENT ENVIRONMENT CHALLENGING AND EVOLVING. Repeated inspection failures Increasing number of 483s Multiple warning letters Consent decrees Disgorgement of profit Systems-based approach.

deirdre
Download Presentation

GMP Compliance: Better to Start Now

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. GMP Compliance: Better to Start Now Presented by: Matthew R. Weinberg, CEO

  2. CURRENT ENVIRONMENTCHALLENGING AND EVOLVING • Repeated inspection failures • Increasing number of 483s • Multiple warning letters • Consent decrees • Disgorgement of profit • Systems-based approach

  3. COMPLIANCE INVOLVESMULTIPLE PROCESSES • Training and culture create the environment and mentality • Quality Assurance monitors the day-to-day and trend actions • FDA regulation mandates several distinct activities • Internal enforcement assures prescribed actions are completed

  4. GMP ACTIONS OFTEN REACTIONARY • Historical focus always after-the-fact • Expense focus creates little incentive for fore thinking • Compliance generally seen as production cost • Viewed as lower priority within an organization

  5. GMP COMPLIANCE OFTEN MISUNDERSTOOD • Perceived as a burden • Corporate view continues to be as an expense • Traditional view is a leash with little up side potential • Rarely seen as a revenue-generating opportunity

  6. CONSEQUENCES PAINFULAND COSTLY • Loss of money • Warner-Lambert estimates $1B* • Abbott close to $1B and growing* • Consent decrees are long standing • Loss of time • Application approvals • Getting new product to market • Loss of image • Damage to credibility *The Gold Sheet, Vol. 36, No. 6, June 2002

  7. CORPORATE CHANGE REQUIRED • GMPs must be integrated into the process, not an additional component • Process must evolve from one of police action to one of forethought • Corporate culture must change

  8. CULTURE CHANGE DRAMATICAND DIFFICULT • Quality function must be valued by management • Increase visibility of quality unit • Visibly exhibit an intolerance for lack of compliance • Quality must be seen as a priority

  9. PROACTIVE APPROACH NECESSARY • Approach regulations proactively • “It is often said at FDA that firms that are in compliance tend to stay in compliance, but once a firm gets out of compliance getting back into compliance is a very steep road to climb. Try to avoid that road.” – Daniel Troy, FDA Chief Counsel

  10. FOCUS ON BUILDING THE RIGHT QUALITY SYSTEM • Create a self-determining culture • Make regulatory mandates obvious and routine, not the focus • Use Quality Assurance as a cost-improvement methodology

  11. PROACTIVE APPROACH TO INCREASING PROFITABILITY • Approach facilities’ inspections proactively • Use third parties • Assess all business operations • Act on things immediately • Change focus from compliance to improvement

  12. DEMONSTRATE THAT COMPLIANCE IS SUBSET OF QUALITY • Make compliance a way of life • Focus on improvement • Enjoy savings from this change

  13. DIFFICULTY IN CHANGING MINDSET • Change from compliance mentality challenging • Vigilance must be maintained • Adaptation in outlying plants will take time

  14. CHANGE BEGINS WITH STUDYAND THOUGHT • First step is to plan for change • Plan should include all elements of change process • Focus on instituting means of process improvement

More Related